13F-HR/A filed by Birchview Capital, LP
Birchview Capital, LP filed this 13F-HR/A for the quarter ended 2024-12-31, filed 2025-06-30, with 68 holding rows worth $122,907,649.
- Accession
- 0001618205-25-000008
- Filer
- CIK 1618205
- Filed
- 2025-06-30
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, amendment of type new holdings, 68 entries on the cover page, a total value of $122,907,649 stated on the cover page (in dollars after the unit check, H1), rows summing to $122,907,649 with VALUE read as dollars as filed, 13F file number 028-16416. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Bristol-Myers Squibb Company | 110122108 | COM | 685,182 | $38,753,882 | dollars as filed | |
| BIODESIX INC | 09075X108 | COM | 5,736,113 | $8,776,253 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 338,400 | $6,209,640 | dollars as filed | |
| ELUTIA INC | 05479K106 | CL A COM | 1,225,489 | $4,583,329 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 304,574 | $4,218,350 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 30,240 | $4,127,760 | dollars as filed | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 74,000 | $3,728,860 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 10,000 | $3,528,400 | dollars as filed | |
| AXOGEN INC | 05463X106 | COM | 197,000 | $3,246,560 | dollars as filed | |
| DOCGO INC | 256086109 | COM | 764,062 | $3,239,623 | dollars as filed | |
| QUIDEL CORP | 74838J101 | COM | 67,619 | $3,012,426 | dollars as filed | |
| PHREESIA INC | 71944F106 | COM | 114,700 | $2,885,852 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 148,000 | $2,578,160 | dollars as filed | |
| MASIMO CORP COM | 574795100 | Stock | 15,280 | $2,525,784 | dollars as filed | |
| HARROW INC | 415858109 | COM | 72,910 | $2,446,131 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 210,000 | $2,316,300 | dollars as filed | |
| OVINTIV INC | 69047Q102 | COM | 52,200 | $2,114,100 | dollars as filed | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 78,000 | $2,078,700 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 48,000 | $1,852,800 | dollars as filed | |
| EQT CORP COM | 26884L109 | Stock | 34,619 | $1,596,282 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 310,930 | $1,467,590 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 50,000 | $1,438,000 | dollars as filed | |
| TREACE MED CONCEPTS INC | 89455T109 | COM | 161,350 | $1,200,444 | dollars as filed | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 31,000 | $923,800 | dollars as filed | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 50,000 | $718,000 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 16,000 | $673,120 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 26,000 | $597,480 | dollars as filed | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 30,000 | $593,400 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 67,000 | $567,490 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 58,000 | $532,440 | dollars as filed | |
| CANDEL THERAPEUTICS INC | 137404109 | COMMON STOCK | 60,000 | $520,800 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 40,000 | $494,800 | dollars as filed | |
| INHIBRX BIOSCIENCES INC | 45720N103 | COM | 32,110 | $494,494 | dollars as filed | |
| HALOZYME THERAPEUTICS INC COM | 40637H109 | Stock | 10,000 | $478,100 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 10,000 | $470,400 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 14,000 | $446,740 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 3,500 | $425,565 | dollars as filed | |
| OUTSET MEDICAL INC | 690145107 | COM | 368,766 | $409,330 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 10,000 | $392,000 | dollars as filed | |
| Accelerate Diagnostics | 00430H102 | COM | 325,239 | $390,287 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 125,000 | $377,500 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 10,000 | $361,300 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 20,000 | $353,200 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 51,000 | $346,290 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 8,000 | $345,760 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 4,000 | $338,440 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 40,000 | $300,800 | dollars as filed | |
| ATARA BIOTHERAPEUTICS INC | 046513206 | COM NEW | 22,000 | $292,820 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 15,000 | $287,550 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 419,832 | $283,932 | dollars as filed | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 7,365 | $275,083 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 28,000 | $263,760 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 20,000 | $243,600 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 15,000 | $237,450 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 2,700 | $235,494 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 4,000 | $216,600 | dollars as filed | |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 16,500 | $135,135 | dollars as filed | |
| Direxion Daily Technology Bull 3X Shares | 25459W102 | ETF | 18,000 | $127,800 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 138,176 | $124,994 | dollars as filed | |
| Inflarx Nv | N44821101 | COM | 50,000 | $123,500 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 10,000 | $117,600 | dollars as filed | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 82,000 | $113,160 | dollars as filed | |
| NEUROPACE INC | 641288105 | COMMON STOCK | 10,000 | $111,900 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 10,000 | $78,600 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 28,800 | $63,072 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 17,000 | $51,510 | dollars as filed | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 15,833 | $46,549 | dollars as filed | |
| CERO THERAPEUTICS HLDGS INC | 71902K105 | CLASS A COM | 12,972 | $778 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001618205-25-000001 | superseded | 2025-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001618205-25-000008 | this filing | 2025-06-30 | acceptance time not in the bulk data set |